Authors :
John Croom, MD, PhD – Saint Luke's Marion Bloch Neuroscience Institute
Presenting Author: Christina Cacoulidis, – University of Missouri-Kansas City School of Medicine
Samuel Kim, BA – University of Missouri-Kansas City School of Medicine
Rationale:
Epilepsy is a chronic neurological disorder characterized by recurrent seizures. Although epilepsy-related deaths have historically been relatively rare, the COVID-19 pandemic may have disrupted care and exacerbated demographic and regional disparities. This study examines trends in epilepsy-related mortality before, during, and after the pandemic.
Methods:
Mortality data from 1999–2023 were obtained from the CDC WONDER database (ICD-10 code G40.0). Analyses were stratified by sex, race, age, and U.S. census region. Trends were compared across three periods: pre-COVID (2018–2019), intra-COVID (2020–2021), and post-COVID (2022–2023), using one-way ANOVA and linear regression analysis.
Results:
Conclusions:
Epilepsy-related mortality rose significantly during and after the COVID-19 pandemic. Post-pandemic effects had a larger impact on the epilepsy-related deaths of elderly populations. Future studies could investigate the reasons the Covid-19 pandemic increased epilepsy related deaths particularly in the elderly population.
Funding: N/A